Related Experiment Video
Updated: Nov 10, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Alterations of Left Ventricular Function Persisting during Post-Acute COVID-19 in Subjects without Previously
Mariana Tudoran1,2,3, Cristina Tudoran1,2, Voichita Elena Lazureanu4
1Department VII, Internal Medicine II, Discipline of Cardiology, University of Medicine and Pharmacy "Victor Babes" Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania.
Insights
Post-COVID-19 patients often experience persistent cardiac issues, including left ventricular systolic function alterations and diastolic dysfunction. Elevated myocardial necrosis markers during acute infection may predict future cardiac performance decline.
Area of Science:
- Cardiology
- Infectious Diseases
- Echocardiography
Background:
- Coronavirus disease (COVID-19) is a severe respiratory illness with known cardiovascular complications.
- This study investigates persistent cardiac dysfunction in COVID-19 survivors without prior cardiovascular disease.
Purpose of the Study:
- To assess left ventricular systolic function (LV-SF) and diastolic dysfunction (DD) in COVID-19 patients post-recovery.
- To identify predictors of cardiac dysfunction following moderate COVID-19 pneumonia.
Main Methods:
- 125 patients hospitalized for moderate COVID-19 pneumonia underwent transthoracic echocardiography (TTE) 6-10 weeks after discharge.
- Analysis included in-hospital laboratory data (CK-MB) and thorax CT scans.
- Multivariate regression identified factors associated with LV-SF decrease.
Main Results:
- Transthoracic echocardiography revealed LV-SF alterations in 8.8% and diastolic dysfunction in 16.8% of patients.
- Cardiac dysfunction correlated with initial levels of creatine kinase-MB (CK-MB) and inflammatory markers.
- CK-MB levels, age, and BMI accounted for 65% of the decrease in LV-SF.
Conclusions:
- Left ventricular systolic and diastolic dysfunction are common sequelae of COVID-19 infection.
- These cardiac alterations may contribute to persistent symptoms in post-acute COVID-19.
- Elevated myocardial necrosis markers during acute COVID-19 infection predict subsequent cardiac performance impairment.
Abstract:
(1) Background: Coronavirus infection (Covid-19) has emerged as a severe medical condition, associated with high pulmonary morbidity and often with cardiovascular (CV) complications. This study aims to evidence the persistence of left ventricular (LV) systolic function (LV-SF) alterations and diastolic dysfunction (DD) in COVID-19 patients without history of cardiovascular (CV) diseases by transthoracic echocardiography (TTE). (2) Methods: 125 patients, aged under 55 years, hospitalized during the first outbreak of Covid-19 for moderate pneumonia, underwent a comprehensive cardiologic examination and TTE at 6-10 weeks after discharge. Their initial in-hospital laboratory data and thorax computer tomography (TCT) were accessed from the electronic database of the hospital. (3) Results: with TTE, we documented alterations of LV-SF and DD in 8.8% of patients and in 16.8% only patterns of DD, statistically correlated with the initial levels of creatin-kinase (CK-MB) and inflammatory factors. Multivariate regression analysis evidenced that CK-MB levels, age, and body mass index (BMI) are responsible for 65% of LV-SF decrease. (4) Conclusions: Alterations of LV-SF and DD are frequent in post-acute COVID-19 infection and are responsible for the persistence of symptoms. Elevated myocardial necrosis markers during the acute phase seem to predict subsequent alteration of cardiac performance.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
08:19Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
Published on: July 12, 2022
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies